Amicus Therapeutics Aktie
6,90
EUR
-0,15
EUR
-2,13
%
8,35
USD
-0,14
USD
-1,65
%
Werbung
Amicus Therapeutics Aktie Analyse
17.08.18 | Amicus Therapeutics Neutral | Chardan Capital Markets | |
14.04.16 | Amicus Therapeutics Neutral | Robert W. Baird & Co. Incorporated | |
05.10.15 | Amicus Therapeutics Hold | Lake Street | |
16.09.15 | Amicus Therapeutics Neutral | Chardan Capital Markets |
Werbung
Werbung